speb/financial-data huggingface dataset:
CVRX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 86000.00
CVRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -203000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -203000.00
CVRX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 11536000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 11536000.00
CVRX balance_sheet (annual, 2025-12-31) — Gross PPE: 7269000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7269000.00
CVRX income_statement (annual, 2025-12-31) — Gross Profit: 48340000.00
CVRX income_statement (quarterly, 2025-12-31) — Gross Profit: 13825000.00
CVRX income_statement (annual, 2025-12-31) — Interest Expense: 5827000.00
CVRX income_statement (quarterly, 2025-12-31) — Interest Expense: 1417000.00
CVRX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 5827000.00
CVRX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1417000.00
CVRX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 5045000.00
CVRX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1229000.00
CVRX balance_sheet (annual, 2025-12-31) — Interest Payable: 403000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Interest Payable: 403000.00
CVRX balance_sheet (annual, 2025-12-31) — Inventory: 12205000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Inventory: 12205000.00
CVRX balance_sheet (annual, 2025-12-31) — Invested Capital: 88838000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 88838000.00
CVRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -580000.00
CVRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -68000.00
CVRX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 8974000.00
CVRX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -179000.00
CVRX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
CVRX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CVRX balance_sheet (annual, 2025-12-31) — Leases: 827000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Leases: 827000.00
CVRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 638000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 638000.00
CVRX balance_sheet (annual, 2025-12-31) — Long Term Debt: 49514000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 49514000.00
CVRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 50152000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 50152000.00
CVRX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
CVRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CVRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1706000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1706000.00
CVRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 8974000.00
CVRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -179000.00
CVRX income_statement (annual, 2025-12-31) — Net Income: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Income: -11934000.00
CVRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -11934000.00
CVRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -11934000.00
CVRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11934000.00
CVRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -11934000.00
CVRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -53306000.00
CVRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -11934000.00
CVRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -11934000.00
CVRX income_statement (annual, 2025-12-31) — Net Interest Income: -5827000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Interest Income: -1417000.00
CVRX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CVRX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CVRX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CVRX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CVRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -5827000.00
CVRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1417000.00
CVRX balance_sheet (annual, 2025-12-31) — Net PPE: 3121000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 3121000.00
CVRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -580000.00
CVRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -68000.00
CVRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 39324000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 39324000.00
CVRX income_statement (annual, 2025-12-31) — Normalized EBITDA: -46741000.00
CVRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -10339000.00
CVRX income_statement (annual, 2025-12-31) — Normalized Income: -53306000.00
CVRX income_statement (quarterly, 2025-12-31) — Normalized Income: -11934000.00
CVRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -40170000.00
CVRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -9758000.00
CVRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 86000.00
CVRX income_statement (annual, 2025-12-31) — Operating Income: -51265000.00
CVRX income_statement (quarterly, 2025-12-31) — Operating Income: -11184000.00
CVRX income_statement (annual, 2025-12-31) — Operating Revenue: 56651000.00
CVRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 16024000.00
CVRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 26311607.00
CVRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 26311607.00
CVRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 3069000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3069000.00
CVRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -203000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -203000.00
CVRX income_statement (annual, 2025-12-31) — Other Income Expense: 3768000.00
CVRX income_statement (quarterly, 2025-12-31) — Other Income Expense: 660000.00
CVRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 241000.00
CVRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 61000.00
CVRX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 26000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 26000.00
CVRX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 2001000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 2001000.00
CVRX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3768000.00
CVRX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 660000.00
CVRX balance_sheet (annual, 2025-12-31) — Other Properties: 4411000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 4411000.00
CVRX balance_sheet (annual, 2025-12-31) — Payables: 3926000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Payables: 3926000.00
CVRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 5999000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5999000.00
CVRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6966000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6966000.00
CVRX income_statement (annual, 2025-12-31) — Pretax Income: -53324000.00
CVRX income_statement (quarterly, 2025-12-31) — Pretax Income: -11941000.00
CVRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1546000.00
CVRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 589000.00
CVRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
CVRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CVRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -580000.00
CVRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -68000.00
CVRX balance_sheet (annual, 2025-12-31) — Raw Materials: 8628000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 8628000.00
CVRX balance_sheet (annual, 2025-12-31) — Receivables: 10665000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Receivables: 10665000.00
CVRX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 8311000.00
CVRX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2199000.00
CVRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 756000.00
CVRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 185000.00
CVRX income_statement (annual, 2025-12-31) — Research And Development: 11132000.00
CVRX income_statement (quarterly, 2025-12-31) — Research And Development: 3000000.00
CVRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -590652000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -590652000.00
CVRX income_statement (annual, 2025-12-31) — Selling General And Administration: 88473000.00
CVRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 22009000.00
CVRX balance_sheet (annual, 2025-12-31) — Share Issued: 26311607.00
CVRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 26311607.00
CVRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 11052000.00
CVRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2793000.00
CVRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 39324000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 39324000.00
CVRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 39324000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 39324000.00
CVRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CVRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CVRX income_statement (annual, 2025-12-31) — Tax Provision: -18000.00
CVRX income_statement (quarterly, 2025-12-31) — Tax Provision: -7000.00
CVRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CVRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CVRX balance_sheet (annual, 2025-12-31) — Total Assets: 104794000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 104794000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 88838000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 88838000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Debt: 50504000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 50504000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 39324000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 39324000.00
CVRX income_statement (annual, 2025-12-31) — Total Expenses: 107916000.00
CVRX income_statement (quarterly, 2025-12-31) — Total Expenses: 27208000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 65470000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 65470000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3147000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3147000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 52153000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 52153000.00
CVRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -51265000.00
CVRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -11184000.00
CVRX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 93000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 93000.00
CVRX balance_sheet (annual, 2025-12-31) — Work In Process: 473000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Work In Process: 473000.00
CVRX balance_sheet (annual, 2025-12-31) — Working Capital: 88330000.00
CVRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 88330000.00
CVRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 25042000.00
CVRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 14769000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2998000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 9104000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3083000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 632820000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -869000.00
CVRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26355591.00
CVRX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.50
CVRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 75708000.00
CVRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -122000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 905000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 264000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 72303000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 72303000.00
CVRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 8882000.00
CVRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -122000.00
CVRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -12164000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -834000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -2907000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -198000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Payable: -834000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3741000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 129000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1561000.00
CVRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2249000.00
CVRX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 1561000.00
CVRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3404000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 264000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 29109000.00
CVRX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -43000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 374000.00
CVRX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1888000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2474000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 96750000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 361000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 361000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 9486000.00
CVRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 205000.00
CVRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 205000.00
CVRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26355591.00
CVRX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.50
CVRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — EBIT: -11568000.00
CVRX income_statement (quarterly, 2026-03-31) — EBITDA: -11363000.00
CVRX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1000.00
CVRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 72303000.00
CVRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 8882000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 3367000.00
CVRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -12286000.00
CVRX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 1000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -203000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 9973000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6035000.00
CVRX income_statement (quarterly, 2026-03-31) — Gross Profit: 12881000.00
CVRX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CVRX income_statement (quarterly, 2026-03-31) — Interest Expense: 1551000.00
CVRX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1551000.00
CVRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1294000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Interest Payable: 479000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Inventory: 12403000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 87599000.00
CVRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -122000.00
CVRX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 10000000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Leases: 828000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 544000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 58490000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 59034000.00
CVRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 10000000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1361000.00
CVRX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -43000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Income: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -13120000.00
CVRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -13120000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Interest Income: -1551000.00
CVRX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 10000000.00
CVRX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 10000000.00
CVRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1551000.00
CVRX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1107000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 2952000.00
CVRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -122000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 29109000.00
CVRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -11363000.00
CVRX income_statement (quarterly, 2026-03-31) — Normalized Income: -13120000.00
CVRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -12164000.00
CVRX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1000.00
CVRX income_statement (quarterly, 2026-03-31) — Operating Income: -12161000.00
CVRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 14769000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 26428767.00
CVRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2940000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -203000.00
CVRX income_statement (quarterly, 2026-03-31) — Other Income Expense: 593000.00
CVRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 83000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 26000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2099000.00
CVRX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 593000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 3472000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Payables: 3125000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 5599000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3526000.00
CVRX income_statement (quarterly, 2026-03-31) — Pretax Income: -13119000.00
CVRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 32000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CVRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -122000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Raw Materials: 8413000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Receivables: 9104000.00
CVRX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1888000.00
CVRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 205000.00
CVRX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -43000.00
CVRX income_statement (quarterly, 2026-03-31) — Research And Development: 3084000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -603772000.00
CVRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21958000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 26428767.00
CVRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2916000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 29109000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 29109000.00
CVRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CVRX income_statement (quarterly, 2026-03-31) — Tax Provision: 1000.00
CVRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CVRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 99728000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 87599000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 59395000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 29109000.00
CVRX income_statement (quarterly, 2026-03-31) — Total Expenses: 26930000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 70619000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2978000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 61133000.00
CVRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -12161000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 127000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Work In Process: 623000.00
CVRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 87264000.00
CVS balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
CVS income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
CVS income_statement (annual, 2021-12-31) — Other Special Charges: 452000000.00
CVS cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
CVS cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CVS income_statement (annual, 2022-12-31) — +Operating Expense: 38212000000.00
CVS income_statement (annual, 2022-12-31) — +Total Revenue: 322467000000.00
CVS balance_sheet (annual, 2022-12-31) — Accounts Payable: 14838000000.00
CVS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 11659000000.00
CVS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -21483000000.00
CVS cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CVS balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 908000000.00
CVS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 17562000000.00
CVS income_statement (annual, 2022-12-31) — Basic Average Shares: 1312000000.00
CVS income_statement (annual, 2022-12-31) — Basic EPS: 3.29
CVS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 12691000000.00
CVS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4545000000.00
CVS cash_flow (annual, 2022-12-31) — Capital Expenditure: -2727000000.00
CVS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 18478000000.00
CVS balance_sheet (annual, 2022-12-31) — Capital Stock: 48193000000.00
CVS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 12945000000.00
CVS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 15723000000.00
CVS cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2907000000.00
CVS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -10516000000.00
CVS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5047000000.00
CVS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 16177000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Account Payable: 4260000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Inventory: -1435000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -491000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 6463000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Payable: 5252000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5252000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Receivables: -2971000000.00
CVS cash_flow (annual, 2022-12-31) — Change In Working Capital: 6818000000.00
CVS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2971000000.00
CVS cash_flow (annual, 2022-12-31) — Changes In Cash: 614000000.00
CVS balance_sheet (annual, 2022-12-31) — Commercial Paper: 0.00
CVS balance_sheet (annual, 2022-12-31) — Common Stock: 48193000000.00
CVS cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2907000000.00
CVS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 71469000000.00
CVS cash_flow (annual, 2022-12-31) — Common Stock Payments: -3500000000.00
CVS income_statement (annual, 2022-12-31) — Cost Of Revenue: 267965000000.00
CVS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 18745000000.00
CVS balance_sheet (annual, 2022-12-31) — Current Assets: 65633000000.00
CVS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1678000000.00
CVS balance_sheet (annual, 2022-12-31) — Current Debt: 1778000000.00
CVS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3456000000.00
CVS balance_sheet (annual, 2022-12-31) — Current Liabilities: 69421000000.00
CVS cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2029000000.00
CVS cash_flow (annual, 2022-12-31) — Deferred Tax: -2029000000.00
CVS balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 3228000000.00
CVS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 4224000000.00
CVS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 4224000000.00
CVS income_statement (annual, 2022-12-31) — Diluted Average Shares: 1323000000.00
CVS income_statement (annual, 2022-12-31) — Diluted EPS: 3.26
CVS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 4311000000.00
CVS income_statement (annual, 2022-12-31) — EBIT: 8123000000.00
CVS income_statement (annual, 2022-12-31) — EBITDA: 12347000000.00
CVS balance_sheet (annual, 2022-12-31) — Employee Benefits: 3228000000.00
CVS cash_flow (annual, 2022-12-31) — End Cash Position: 13305000000.00
CVS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -10516000000.00
CVS cash_flow (annual, 2022-12-31) — Free Cash Flow: 13450000000.00
CVS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -475000000.00
CVS income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -2533000000.00
CVS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1264000000.00
CVS balance_sheet (annual, 2022-12-31) — Goodwill: 78150000000.00
CVS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 102953000000.00
CVS balance_sheet (annual, 2022-12-31) — Gross PPE: 52228000000.00
CVS income_statement (annual, 2022-12-31) — Gross Profit: 54502000000.00
CVS balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 989000000.00
CVS income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CVS income_statement (annual, 2022-12-31) — Interest Expense: 2287000000.00
CVS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2287000000.00
CVS balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -559000000.00
CVS balance_sheet (annual, 2022-12-31) — Inventory: 19090000000.00
CVS balance_sheet (annual, 2022-12-31) — Invested Capital: 123723000000.00
CVS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5047000000.00
CVS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 18551000000.00
CVS balance_sheet (annual, 2022-12-31) — Investments And Advances: 21096000000.00
CVS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CVS balance_sheet (annual, 2022-12-31) — Land And Improvements: 1996000000.00
CVS balance_sheet (annual, 2022-12-31) — Leases: 6238000000.00
CVS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 16800000000.00
CVS balance_sheet (annual, 2022-12-31) — Long Term Debt: 50476000000.00
CVS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 67276000000.00
CVS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CVS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4211000000.00
CVS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 21821000000.00
CVS balance_sheet (annual, 2022-12-31) — Minority Interest: 300000000.00
CVS income_statement (annual, 2022-12-31) — Minority Interests: -16000000.00
CVS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1388000000.00
CVS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -3500000000.00
CVS balance_sheet (annual, 2022-12-31) — Net Debt: 39309000000.00
CVS income_statement (annual, 2022-12-31) — Net Income: 4311000000.00
CVS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 4311000000.00
CVS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4327000000.00
CVS income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CVS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 4311000000.00
CVS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 4311000000.00
CVS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4327000000.00
CVS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4327000000.00
CVS income_statement (annual, 2022-12-31) — Net Interest Income: -2287000000.00
CVS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1017000000.00
CVS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -4211000000.00
CVS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -4211000000.00
CVS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2287000000.00
CVS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -449000000.00
CVS cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 85000000.00
CVS balance_sheet (annual, 2022-12-31) — Net PPE: 30745000000.00
CVS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2727000000.00
CVS cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CVS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -31484000000.00
CVS balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4016000000.00
CVS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4016000000.00
CVS balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3228000000.00
CVS income_statement (annual, 2022-12-31) — Normalized EBITDA: 20683000000.00
CVS income_statement (annual, 2022-12-31) — Normalized Income: 10487976000.00
CVS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 16177000000.00
CVS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2058000000.00
CVS income_statement (annual, 2022-12-31) — Operating Income: 16290000000.00
CVS income_statement (annual, 2022-12-31) — Operating Revenue: 322467000000.00
CVS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1300000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Current Assets: 2636000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1778000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2817000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1264000000.00
CVS income_statement (annual, 2022-12-31) — Other Income Expense: -8167000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 24803000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Inventories: 19649000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Investments: 2545000000.00
CVS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 332000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4620000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 12565000000.00
CVS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 169000000.00
CVS income_statement (annual, 2022-12-31) — Other Operating Expenses: 38212000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Payable: 29565000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Properties: 17628000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Receivables: 15617000000.00
CVS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 2778000000.00
CVS income_statement (annual, 2022-12-31) — Other Special Charges: 5803000000.00
CVS balance_sheet (annual, 2022-12-31) — Payables: 44403000000.00
CVS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 63148000000.00
CVS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CVS income_statement (annual, 2022-12-31) — Pretax Income: 5836000000.00
CVS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 551000000.00
CVS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CVS cash_flow (annual, 2022-12-31) — Purchase Of Business: -1388000000.00
CVS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -7746000000.00
CVS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2727000000.00
CVS balance_sheet (annual, 2022-12-31) — Receivables: 27276000000.00
CVS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 267965000000.00
CVS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 4224000000.00
CVS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4211000000.00
CVS cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3500000000.00
CVS income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS balance_sheet (annual, 2022-12-31) — Retained Earnings: 56398000000.00
CVS cash_flow (annual, 2022-12-31) — Sale Of Investment: 6729000000.00
CVS cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CVS balance_sheet (annual, 2022-12-31) — Share Issued: 1758000000.00
CVS cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CVS cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CVS income_statement (annual, 2022-12-31) — Special Income Charges: -8336000000.00
CVS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 447000000.00
CVS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 71469000000.00
CVS balance_sheet (annual, 2022-12-31) — Tangible Book Value: -31484000000.00
CVS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -2159024000.00
CVS income_statement (annual, 2022-12-31) — Tax Provision: 1509000000.00
CVS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CVS balance_sheet (annual, 2022-12-31) — Total Assets: 228275000000.00
CVS balance_sheet (annual, 2022-12-31) — Total Capitalization: 121945000000.00
CVS balance_sheet (annual, 2022-12-31) — Total Debt: 70732000000.00
CVS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 71769000000.00
CVS income_statement (annual, 2022-12-31) — Total Expenses: 306177000000.00
CVS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 156506000000.00
CVS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 162642000000.00
CVS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 87085000000.00
CVS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 7954000000.00
CVS income_statement (annual, 2022-12-31) — Total Unusual Items: -8336000000.00
CVS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -8336000000.00
CVS balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 458000000.00
CVS balance_sheet (annual, 2022-12-31) — Treasury Stock: 31858000000.00
CVS balance_sheet (annual, 2022-12-31) — Working Capital: -3788000000.00
CVS income_statement (annual, 2023-12-31) — +Operating Expense: 39832000000.00
CVS income_statement (annual, 2023-12-31) — +Total Revenue: 357776000000.00
CVS balance_sheet (annual, 2023-12-31) — Accounts Payable: 14897000000.00
CVS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 15622000000.00
CVS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -20699000000.00
CVS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 152000000.00
CVS balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
CVS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 18582000000.00
CVS income_statement (annual, 2023-12-31) — Basic Average Shares: 1285000000.00
CVS income_statement (annual, 2023-12-31) — Basic EPS: 6.49
CVS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13305000000.00
CVS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4571000000.00
CVS cash_flow (annual, 2023-12-31) — Capital Expenditure: -3031000000.00
CVS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 17775000000.00
CVS balance_sheet (annual, 2023-12-31) — Capital Stock: 48992000000.00
CVS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 8196000000.00
CVS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 11455000000.00
CVS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -3132000000.00
CVS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2683000000.00
CVS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -20889000000.00
CVS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 13426000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Account Payable: 3618000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Inventory: 1233000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -510000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1540000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Payable: 4012000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4012000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Receivables: -6260000000.00
CVS cash_flow (annual, 2023-12-31) — Change In Working Capital: 15000000.00
CVS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -6260000000.00
CVS cash_flow (annual, 2023-12-31) — Changes In Cash: -4780000000.00
CVS balance_sheet (annual, 2023-12-31) — Commercial Paper: 200000000.00
CVS balance_sheet (annual, 2023-12-31) — Common Stock: 48992000000.00
CVS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -3132000000.00
CVS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 76461000000.00
CVS cash_flow (annual, 2023-12-31) — Common Stock Payments: -2012000000.00
CVS income_statement (annual, 2023-12-31) — Cost Of Revenue: 303345000000.00
CVS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 23515000000.00
CVS balance_sheet (annual, 2023-12-31) — Current Assets: 67858000000.00
CVS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1741000000.00
CVS balance_sheet (annual, 2023-12-31) — Current Debt: 2972000000.00
CVS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4713000000.00
CVS balance_sheet (annual, 2023-12-31) — Current Liabilities: 79189000000.00
CVS cash_flow (annual, 2023-12-31) — Deferred Income Tax: -676000000.00
CVS cash_flow (annual, 2023-12-31) — Deferred Tax: -676000000.00
CVS balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 3250000000.00
CVS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4366000000.00
CVS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4366000000.00
CVS income_statement (annual, 2023-12-31) — Diluted Average Shares: 1290000000.00
CVS income_statement (annual, 2023-12-31) — Diluted EPS: 6.47
CVS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 8344000000.00
CVS income_statement (annual, 2023-12-31) — EBIT: 13831000000.00
CVS income_statement (annual, 2023-12-31) — EBITDA: 18197000000.00
CVS balance_sheet (annual, 2023-12-31) — Employee Benefits: 3250000000.00
CVS cash_flow (annual, 2023-12-31) — End Cash Position: 8525000000.00
CVS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2683000000.00
CVS cash_flow (annual, 2023-12-31) — Free Cash Flow: 10395000000.00
CVS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CVS income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CVS income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -349000000.00
CVS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -297000000.00
CVS balance_sheet (annual, 2023-12-31) — Goodwill: 91272000000.00
CVS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 120506000000.00
CVS balance_sheet (annual, 2023-12-31) — Gross PPE: 51134000000.00
CVS income_statement (annual, 2023-12-31) — Gross Profit: 54431000000.00
CVS balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 1183000000.00
CVS income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CVS income_statement (annual, 2023-12-31) — Interest Expense: 2658000000.00
CVS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2658000000.00
CVS balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -607000000.00
CVS balance_sheet (annual, 2023-12-31) — Inventory: 18025000000.00
CVS balance_sheet (annual, 2023-12-31) — Invested Capital: 138071000000.00
CVS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -20889000000.00
CVS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 19765000000.00
CVS balance_sheet (annual, 2023-12-31) — Investments And Advances: 23019000000.00
CVS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 16098000000.00
CVS balance_sheet (annual, 2023-12-31) — Land And Improvements: 1958000000.00
CVS balance_sheet (annual, 2023-12-31) — Leases: 6511000000.00
CVS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 16034000000.00
CVS balance_sheet (annual, 2023-12-31) — Long Term Debt: 58638000000.00
CVS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 74672000000.00
CVS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 10898000000.00
CVS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3166000000.00
CVS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 20842000000.00
CVS balance_sheet (annual, 2023-12-31) — Minority Interest: 175000000.00
CVS income_statement (annual, 2023-12-31) — Minority Interests: -24000000.00
CVS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -16612000000.00
CVS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2012000000.00
CVS balance_sheet (annual, 2023-12-31) — Net Debt: 53414000000.00
CVS income_statement (annual, 2023-12-31) — Net Income: 8344000000.00
CVS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 8344000000.00
CVS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 8368000000.00
CVS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 8344000000.00
CVS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 8344000000.00
CVS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 8368000000.00
CVS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 8368000000.00
CVS income_statement (annual, 2023-12-31) — Net Interest Income: -2658000000.00
CVS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1314000000.00
CVS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 7932000000.00
CVS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 7732000000.00
CVS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2658000000.00
CVS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -382000000.00
CVS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 68000000.00
CVS balance_sheet (annual, 2023-12-31) — Net PPE: 30435000000.00
CVS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -3031000000.00
CVS cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 200000000.00
CVS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -44045000000.00
CVS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4311000000.00
CVS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 4311000000.00
CVS balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3250000000.00
CVS income_statement (annual, 2023-12-31) — Normalized EBITDA: 19053000000.00
CVS income_statement (annual, 2023-12-31) — Normalized Income: 8985144000.00
CVS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 13426000000.00
CVS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 349000000.00
CVS income_statement (annual, 2023-12-31) — Operating Income: 14599000000.00
CVS income_statement (annual, 2023-12-31) — Operating Revenue: 357776000000.00
CVS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1288000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Current Assets: 3151000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2772000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1141000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -297000000.00
CVS income_statement (annual, 2023-12-31) — Other Income Expense: -768000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 29234000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Inventories: 18632000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Investments: 3254000000.00
CVS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 264000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 4660000000.00
CVS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 11670000000.00
CVS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 88000000.00
CVS income_statement (annual, 2023-12-31) — Other Operating Expenses: 39832000000.00